Abnormal coagulation dynamics, including disseminated intravascular coagulopathy,
pulmonary embolism, venous thromboembolism and risk of thrombosis are often associated …

Accumulating evidence into the pathogenesis of COVID-19 highlights a hypercoagulability
state with high risk of life-threatening thromboembolic complications. However, the …

A State of the Art lecture titled “Platelet‐leukocyte interactions in COVID‐19: Contributions to
hypercoagulability, inflammation and disease severity” was presented at the International …

Background Patients with COVID-19 are at increased risk of thrombosis, which is associated
with altered platelet function and coagulopathy, contributing to excess mortality. Objectives …

Despite the worldwide diffusion of SARS-CoV-2 infection, still little is known concerning the
mechanism leading to multi-organ damage in coronavirus disease 2019 (COVID-19). It is …

Background Thrombocytopenia is associated with increased mortality in COVID-19 patients.
Objective To determine the association between thrombocytopenia and alterations in host …

Introduction Coagulation dysfunction and thromboembolism emerge as strong comorbidity
factors in severe COVID‐19. However, it is unclear when particularly platelet activation …

Coronavirus Disease 2019 (COVID-19), caused by the novel Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2), has affected over 30 million globally to date …

SARS-CoV-2 has spread rapidly worldwide, causing the COVID-19 pandemic. Platelet
activation and platelet-leukocyte complex formation are proposed to contribute to disease …

Although thrombosis frequently occurs in infectious diseases, the coagulopathy associated
with COVID-19 has unique characteristics. Compared with bacterial sepsis, COVID-19 …